Inicio > CUSACOVICH TORRES, IVAN

CUSACOVICH TORRES, IVAN

PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Medicina, Dermatología y Toxicología
 
ivan.cusacovich@uva.es

Índice H en Scopus: 6
 

[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80781]], camposKey:0014-2565 2023-12-01 Treatment of systemic lupus erythematosus: New therapeutic options Tratamiento del lupus eritematoso sistémico: nuevas opciones terapéuticas629639, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80782]], camposKey:2056-5933 2023-09-06 Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80431]], camposKey:0014-2565 2023-08-01 Prevalence of nonalcoholic fatty liver disease in a Spanish town: A population-based study Prevalencia de esteatosis hepática no alcohólica en una ciudad española: estudio poblacional396404, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77332]], camposKey:0002-9343 2023-05-01 Growing Pulmonary Nodule of Unknown Origin in a 61-Year-Old Woman446448, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73437]], camposKey:0014-2972 2023-01-01 Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID-19 pneumonia: An open-label randomised trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78915]], camposKey:0014-2565 2023-01-01 Prevalence of nonalcoholic fatty liver disease in a Spanish town: a population-based study396404, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81412]], camposKey:0014-2565 2023-01-01 Tratamiento del lupus eritematoso sistémico: nuevas opciones terapéuticas629639, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75970]], camposKey:1661-6596 2022-12-01 Dyslipidemia and Inflammation as Hallmarks of Oxidative Stress in COVID-19: A Follow-Up Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65789]], camposKey:0939-4753 2021-08-26 Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-1926192627, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77333]], camposKey:2659-6636 2021-07-01 Should We Anticoagulate a Pulmonary Embolism in a Patient With Cerebrovascular Accident and Recent Haemorrhagic Transformation? ¿Se debería anticoagular un tromboembolismo pulmonar en un paciente con accidente cerebrovascular y transformación hemorrágica reciente?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77334]], camposKey:2077-0383 2021-06-02 Exercise ventilatory inefficiency in post¿covid¿19 syndrome: Insights from a prospective evaluation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66268]], camposKey:0962-9351 2021-01-01 Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66176]], camposKey:0172-8172 2020-02-01 The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey303311, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77646]], camposKey:1699-258X 2006-01-01 Registrolesaf. Features of patients with systemic lupus erythematosus and antiphospholipid syndrome registered by rheumatologists and internists Registrolesaf. Características de los pacientes con lupus eritematoso sistémico síndrome antifosfolipídico registrados por usuarios médicos especialistas en reumatología y medicina interna131136][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][]

AYUDA A LA INVESTIGACIÓN

OTROS

PUBLICACIONES

Artículos de revista (14)

Gonzalez-Garcia A.; Cusacovich I.; Ruiz-Irastorza G. Treatment of systemic lupus erythematosus: New therapeutic options Tratamiento del lupus eritematoso sistémico: nuevas opciones terapéuticas . Revista clínica española: publicación oficial de la Sociedad Española de Medicina Interna 2023; 223(10): 629-639

Enlace a la publicación
Ver Todos
   
Cargando información ...
Universidad de Valladolid - Copyright Universidad de Valladolid - Todos los derechos reservados